One of the top relievers in Japan, right-hander Kyuji Fujikawa, is a free agent eligible to sign with MLB teams without going through the traditional posting process and Gerry Fraley of the Dallas Morning News reports that the Rangers are among multiple teams interested.
Fujikawa’s numbers in Japan are amazing. In eight years he’s never had an ERA higher than 2.01 and this season, at age 32, he posted a 1.32 ERA. He has 220 career saves and 914 strikeouts in 703 innings.
Plenty of Japanese relievers have had success coming to America, including Kazuhiro Sasaki, Takashi Saito, Shigetoshi Hasegawa, Hideki Okajima, Akinori Otsuka, and Koji Uehara. Fujikawa might be the best of the bunch in terms of his performance in Japan.
Phil Hughes was officially designated for assignment by the Twins on Tuesday, the culmination of multiple injury-plagued seasons and poor performance.
Things couldn’t have started out much better for Hughes in Minnesota. The former Yankees hurler joined the Twins on a three-year, $24 million contract in December of 2013 and reeled off a 3.52 ERA over 32 starts during his first season with the club. He set the MLB record (which still stands, by the way) for single season strikeout-to-walk ratio and even received some downballot Cy Young Award consideration. The big year resulted in the two sides ripping up their previous agreement with a new five-year, $58 million deal, but it was all downhill after that.
Hughes took a step back with a 4.40 ERA in 2015 and struggled with a 5.95 ERA over 11 starts and one relief appearance in 2016 before undergoing surgery for thoracic outlet syndrome. He wasn’t any better upon his return last year, putting up a 5.87 ERA in nine starts and five relief appearances. Hughes missed time with a biceps issue and required a thoracic outlet revision surgery in August. He began this year on the disabled list with an oblique injury, only to put up a 6.75 ERA over two starts and five relief appearances before the Twins decided to turn the page this week.
Hughes is still owed the remainder of his $13.2 million salary for this year and another $13.2 million next year. The deal didn’t work out as anyone would have hoped, but unfortunately this is another case of health just not cooperating.